T

TCI Peptide Therapeutics

4 employees

Endevica Bio is a biotechnology company that develops drugs to treat cachexia.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Therapeutics
Drug Delivery
Drug Development
Drug Design
Cachexia
Peptides

Date founded

2009

Funding rounds raised

Total raised

$2.3M

from 1 investors over 1 rounds

T

TCI Peptide Therapeutics raised $2.3M on September 1, 2016

Investors: National Cancer Institute

FAQ